The present invention generally relates to a system and method for treatment of aortic dissection and more particularly, it pertains to a medical implant that functionally occludes false lumen formed between layers of aorta.
An aortic dissection is a dangerous condition with a high mortality rate. In an aortic dissection, a tear typically develops in the intima of the aorta that propagates along the vessel wall separating the inner layer of the aorta from the outer layer. Blood enters the space between the layers creating a false lumen. Several additional tears or entry points can be created between true lumen of the aorta and the false lumen. In the acute phase, dissections may close off perfusion from the aorta to vital organs. In the chronic phase, the weakened tissue can develop into aneurysm and ultimately rupture. According to the Stanford classification, dissections involving the ascending aorta are referred to as type A dissections and dissections involving only the descending aorta are referred to as type B dissections. Current treatments for dissections include medical management to lower the blood pressure of the patient and reduce the hemodynamic stresses on the diseased vessel. If dissections are symptomatic, surgical intervention is necessary. Portions of the diseased aorta are replaced by a surgical graft and the dissection flap is reattached. More recently, endovascular stent grafts have been used to close the primary entry point into the false lumen with the goal to thrombose the false lumen and maintain patency of the true lumen. Often only the primary entry point of a dissection is covered by the stent graft allowing continuous pressurization of the false lumen through secondary entry points. Long term, a pressurized false lumen tends to expand and could lead to aneurysm. The presence of only partial thrombosis with comparison to a fully thrombosed or patent false lumen increases the risk of death by a factor of 2.7 (Tsai et al. N Engl J Med 2007; 357:349-59). Even with endovascular intervention, there is evidence to suggest that treatment is not as effective to completely thrombose the false lumen as it should be (Sayer et al. Eur J Vasc Endovasc Surg 2008; 36(5):522-9). Further, it appears that endovascular stent graft treatment is not an effective treatment for chronic type B dissection patients, with just 36% of patients developing a fully thrombosed false lumen 2 years post-op.
There is ample clinical data suggesting that complete occlusion/thrombosis of the false lumen is not occurring in a large number of patients undergoing treatment for acute and chronic type A and type B aortic dissections. This is of particular concern, given the evidence supporting the importance of complete false lumen occlusion/thrombosis. There is a clear need for an improved method to treat aortic dissections. The current application provides novel solutions to the treatment of aortic dissections.
In order to achieve a fully thrombosed false lumen, numerous cases of false lumen embolization and/or occlusion techniques have been documented, with limited success. All share the common goal of initiating thrombosis by insertion of an embolization device (coils, plug or stent graft) into the false lumen, most frequently via the secondary entry tears [the primary entry tears are frequently covered by an endovascular stent graft].
In a review by Hofferbeth et al. (J Thorac Cardiovasc Surg 2014; 147(4)21240-5), 10 patients undergoing embolization in order to treat continued false lumen perfusion after using endovascular stent grafting only 20% patients had full false lumen thrombosis in both the thoracic and abdominal aorta (using coils and balloon occlusion), while the rest had at least some partial thrombosis. In another study by Idrees et al. (J Vasc Surg 2014; 60(6):1507-13) where primarily covered stent plugs/occluders were inserted into the false lumen, 71% of the patients had a fully thrombosed false lumen—a better result than Hofferbeth et al., but still markedly suboptimal.
While the aforementioned literature points to embolization as a possible approach to cause complete false lumen thrombosis, it has the following key limitations: (a) limited clinical efficacy—this can be attributed to the geometrically inadequate conformation achieved by such devices, which leads to persistent leak sites allowing perfusion of the false lumen through the re-entry tear—the shape of the false lumen in that of a crescent (in cross-section) and it is geometrically not possible to completely fill this space/cross-section with the currently available embolization devices—there will always be some space left unoccluded (b) limited commercial adoption/usage of the approach as: (i) the coils, plugs, etc. are not indicated for occluding a large volume/space such as a re-entry tear of an aortic dissection, and therefore there is no existing direction on methods of use in such an application (ii) it is extremely difficult to establish standard procedures/instructions for use for such devices relating to treatment of an aortic dissection as they are not inherently designed for this application (are used as “make do” devices).
An additional approach, as discussed in prior art U.S. Pat. No. 9,393,100B2, is to fill the false lumen with an inflatable bag. This approach has similar limitations to the embolization devices, where geometrically there will be a non-conformance of the bag to the false lumen thereby limiting the clinical efficacy.
The cross-section of the false lumen has a substantially crescent shape. The existing devices and techniques are unable to completely occlude crescent shaped false lumen owing to its geometry. Thus, there is a need for an implant that can completely occlude the re-entry tear of such shape by addressing its geometry.
Before the present systems and methods, enablement are described, it is to be understood that this application is not limited to the particular systems, and methodologies described, as there can be multiple possible embodiments which are not expressly illustrated in the present disclosures. It is also to be understood that the terminology used in the description is for the purpose of describing the particular versions or embodiments only and is not intended to limit the scope of the present application.
It is an object of the present invention to provide a stent graft or implant that functionally fully occludes the false lumen due to its geometric shape and constructional features.
It is an object of the present invention to provide a stent graft that has substantially same shape as of cross-section of the false lumen.
It is an object of the present invention to provide a stent graft that enables complete thrombosis in the false lumen by blocking blood flow through to the false lumen.
It is an object of the present invention to provide a balloon that enables the said stent graft to functionally fit better in the anatomy of the false lumen.
Embodiments of the present invention disclose a system for treating an aortic dissection, the system comprising a stent graft for deploying in a false lumen. The said stent graft comprises: a graft structure comprising an inner graft and an outer graft. The inner graft has a top edge and a bottom edge, and the outer graft has a top edge and a bottom edge. The said stent graft further comprises a stent structure secured to the graft structure. The stent structure comprises at least one inner stent and at least one outer stent connected to the graft structure, wherein at least one inner stent is connected to the inner graft and at least one outer stent is connected to the outer graft. Either the top edge of the inner graft and the top edge of the outer graft are joined together to close the top edge of the stent graft, or the bottom edge of the inner graft and the bottom edge of the outer graft are joined together to close the bottom edge of the stent graft, or both the top and bottom edges of the stent graft are closed in the manner described. The said stent graft is configured to block the blood flow through the false lumen.
In an embodiment, the system comprises a balloon for enabling the said stent graft to functionally fit better in the anatomy of the false lumen.
In an embodiment, the system comprises a catheter for endovascularly deploying the said stent graft in the false lumen.
In an embodiment, the inner graft has a larger radius of curvature than the outer graft.
In an embodiment, the inner graft, the outer graft, the inner stents and the outer stents are connected to define the overall crescent shape of the said stent graft.
In an embodiment, a hole is provided at the top edge of the said stent graft.
In an embodiment, the hole is provided at the top and bottom edges of the said stent graft where the said stent graft has closed both top and bottom edges.
In an embodiment, the balloon has a cutting or ablating arrangement at the tip of the balloon to make a hole at the top edge of the said stent graft in situ.
In an embodiment, the system comprises a true lumen stent graft for deploying in a true lumen wherein the true lumen stent graft permits blood flow through the true lumen. The true lumen stent graft is substantially tubular in shape and circular in cross section and is generally known in the conventional art for the treatment of aortic dissections.
Embodiments of the present invention disclose a method for treating an aortic dissection. The method comprising steps of providing a stent graft wherein the said stent graft comprises: a graft structure comprising an inner graft and an outer graft; wherein the inner graft has a top edge and a bottom edge; and the outer graft has a top edge and a bottom edge; a stent structure secured to the graft structure; wherein the stent structure comprises at least one inner stent and at least one outer stent connected to the graft structure; wherein at least one inner stent is connected to the inner graft and at least one outer stent is connected to the outer graft; wherein the top edge of the inner graft and the top edge of the outer graft are joined together to close the top edge of the said stent graft; deploying the said stent graft in the false lumen of an aortic dissection at/around re-entry point; deploying a true lumen stent graft in a true lumen of an aortic dissection; wherein the said stent graft deployed in the false lumen blocks blood flow from flowing through the false lumen and the true lumen stent graft permits blood flow from flowing through the true lumen.
In an embodiment, the method comprises making a hole at the top edge of the said stent graft in situ.
In an embodiment, the method comprises making a hole at the top edge of the said stent graft by using the cutting or ablating arrangement of the balloon.
In an embodiment, the method comprises endovascularly deploying the said stent graft in the false lumen by using a catheter.
In an embodiment, the method comprises deploying a balloon to enable the said stent graft to functionally fit better in the anatomy of the false lumen.
In an embodiment, the inner graft, the outer graft, the inner stents and the outer stents are connected to define the overall crescent shape of the said stent graft.
In an embodiment, the bottom edge of the inner graft and the bottom edge of the outer graft are joined together to close the bottom edge of the said stent graft.
In an embodiment, the top and bottom edges of the inner graft and the top and bottom edges of the outer graft are respectively joined together to close the top and bottom edges of the said stent graft.
Various objects, features, aspects and advantages of the present invention will become more apparent from the following detailed description of the embodiments of the invention, along with the accompanying drawings in which like numerals represent like components.
The foregoing summary, as well as the following detailed description of preferred embodiments, is better understood when read in conjunction with the appended drawings. There is shown in the drawings example embodiments, however, the application is not limited to the specific system and method disclosed in the drawings.
Some embodiments, illustrating its features, will now be discussed in detail. The words “comprising,” “having,” “containing,” and “including,” and other forms thereof, are intended to be equivalent in meaning and be open ended in that an item or items following any one of these words is not meant to be an exhaustive listing of such item or items, or meant to be limited to only the listed item or items. It must also be noted that as used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise. Although any methods, and systems similar or equivalent to those described herein can be used in the practice or testing of embodiments, the preferred methods, and systems are now described. The disclosed embodiments are merely exemplary.
The various features and embodiments of a system and method for treatment of aortic dissection by using a stent graft of the present invention will now be described in conjunction with the accompanying figures, namely
The graft structure 110 comprises an inner graft 112 and an outer graft 118. The inner graft 112 has a first side edge 113, a top edge 114, a second side edge 115 and a bottom edge 116. The outer graft 118 has a first side edge 119, a top edge 120, a second side edge 121 and a bottom edge 122. The first side edge 113 of the inner graft 112 is connected to the first side edge 119 of the outer graft 118. The second side edge 115 of the inner graft 112 is connected to the second side edge 121 of the outer graft 118. The graft structure 110 is made up of an impermeable or low porosity material and the material could include but not limited to: polyethylene terephthalate (PET), polyurethane (PU), polytetrafluoroethylene (PTFE) and so on.
As seen in
Each inner stent 132 as well as outer stent 142 has a preferably sinusoidal shape comprising a series of peaks and troughs wherein each inner stent 132 has total peaks P1 and the total troughs T1, wherein each outer stent 142 has total peaks P2 and the total troughs T2. As seen in
Each inner stent 132 has a first end 133 and an opposite second end 134. Each outer stent 142 has a first end 143 and an opposite second end 144 (see
The inner graft 112, the outer graft 118, the inner stents 132 and the outer stents 142 are thus connected to define the overall crescent shape of the stent graft 100. The crescent shape of the stent graft 100 is a result of different radius/diameter of curvature [corresponding to the arc] or arc length for the inner graft 112 and the outer graft 118. Preferably, the inner stents 132 have a larger radius of curvature than the outer stents 142. As seen in front view in
As seen in
As further seen in
In another embodiment (not shown in figures), the inner stent 132 and the outer stent 142 are substantially similar such that both the inner stent 132 and the outer stent 142 have same number of peaks and troughs as well as same wire diameter such that P1 is equal to P2, T1 is equal to T2 and D1 is equal to D2.
In another embodiment (not shown in figures), the inner stent 132 and the outer stent 142 may have a different number of peaks and troughs as well as different wire diameter. In an exemplary embodiment, the inner stent 132 has a larger number of peaks and troughs than the outer stent 142 such that P1 is larger than P2, and T1 is larger than T2. In an exemplary embodiment, the outer stent 142 is made from a wire diameter larger than the wire diameter of the inner stent 132 such that D2 is larger than D1. Further, each of the inner stent 132 and the outer stent 142 may have different base diameter and overall height as further described later in the description and seen in
In another embodiment (not shown in figures), both outer stents 142 of the pair of outer stents 142 are integrally connected (formed) as a one-piece unit. The method/technique for integrally connecting the pair of outer stents 142 could include but not limited to: wire drawing, laser cutting, 3d printing and so on. Similarly, in another embodiment, both inner stents 132 of the pair of inner stents 132 are integrally connected as a one-piece unit. Additionally, in some embodiments, each of the outer stents 142 may be integrally connected with corresponding inner stents 132 to form a single continuous piece/unitary structure. Thus, as exemplified in
In another embodiment (not shown in figures), the first side edge 113 of the inner graft 112 is connected and/or integrally joined/manufactured to the first side edge 119 of the outer graft 118 by various techniques such as but not limited to: suturing, stapling, adhesive joining, clips, compression heat sealing and so on. Similarly, the second side edge 115 of the inner graft 112 is connected and/or integrally joined/manufactured to the second side edge 121 of the outer graft 118 by various techniques such as but not limited to: suturing, stapling, adhesive joining, clips, compression heat sealing and so on.
In another embodiment (not shown in figures), the graft structure 110 is woven/fabricated such that the top edge 114 of inner graft 112 and the top edge 120 of the outer graft 118 are integrally joined/manufactured together, thereby forming the closed top edge 105 of the stent graft 100. Further, the first side edge 113 of the inner graft 112 is integrally joined/manufactured to the first side edge 119 of the outer graft 118 and the second side edge 115 of the inner graft 112 is integrally joined/manufactured to the second side edge 121 of the outer graft 118 respectively.
In another embodiment (not shown in figures), the closed top edge 105 of the stent graft 100 is formed by bringing the top edge 114 of inner graft 112 in close proximity with the top edge 120 of the outer graft 118, and then afterwards suturing/heat sealing the top edge 120 to the top edge 114, thereby forming the closed top edge 105 of the stent graft 100.
In another embodiment as seen in
In another embodiment as seen in
In an embodiment as seen in
As shown in
As seen in
In an embodiment, the true lumen stent graft 170 is configured such that it blocks blood flow from flowing in the false lumen 26 through the primary entry point 10. Further, in another embodiment, multiple true lumen stent grafts 170 are deployed in the true lumen 28. In the case of multiple true lumen stent grafts 170, the true lumen stent grafts 170 can be positioned adjacent to one another, spaced apart or can be positioned relative to one another so as to at least partially overlap. The true lumen stent grafts 170 can be flexible so as to conform to the curvature of the aorta. Some embodiments of the true lumen stent grafts 170 can have large spaces between the struts of stent to allow for flow into branch vessels of the aorta.
As seen in
In another embodiment as shown in
As seen in
In an embodiment, the graft structure 110 is woven/fabricated such that the bottom edge 116 of inner graft 112 and the bottom edge 122 of the outer graft 118 are integrally joined together, thereby forming the closed bottom edge (not shown in figures) of the stent graft 100′.
In another embodiment, the closed bottom edge (not shown in figures) of the stent graft 100′ is formed by bringing the bottom edge 116 of inner graft 112 in close proximity with the bottom edge 122 of the outer graft 118, and then afterwards suturing/heat sealing the bottom edge 122 to the bottom edge 116, thereby closing the bottom edge of the stent graft 100′.
In an embodiment (not shown in figures), the hole(s) 125 is integrally formed at the closed top edge 105 of the stent graft 100″ or at the closed top and bottom edges 105,105′ during manufacturing of the stent graft 100″ and stent graft 100′ respectively using a suitable technique including but not limited to drilling, punching, suturing and so on.
In another embodiment (not shown in figures), the hole(s) 125 is made of a material such that after sufficient and/or predetermined time, the hole(s) 125 is automatically closed such that blood perfusion will not take place from the hole(s) 125 after sufficient and/or predetermined time.
In another embodiment (not shown in figures), the hole(s) 125 has constructional design features such that after sufficient time, the hole(s) 125 is automatically closed such that blood perfusion will not take place from the hole(s) 125 after sufficient time.
In another embodiment, the hole(s) 125 is formed in situ during/after deployment of the stent graft 100″ in the false lumen 26 using a balloon catheter 150 having a balloon 160, and an electrode running across the catheter tube up to the tip, which will be described in detail in below description.
Further, in an embodiment, a crescent-shaped balloon 160 is deployed using the catheter 150. The balloon 160 is inflatable and initially introduced in deflated state. The balloon 160 is later inflated to desired pressure or desired volume and is made to contact with the deployed stent graft (100, 100′, 100″) thereby enabling the stent graft (100, 100′, 100″) to functionally fit better in the anatomy of the false lumen 26. Afterwards, the balloon is deflated and the catheter 150 is removed from the patient body. The balloon 160 is made of a flexible/compliant or semi-compliant material such as but not limited to: polyurethane (PU), latex, and so on.
In another embodiment (not shown in figures), the crescent-shaped balloon 160 could also function as an inflatable tip (not shown in figures) such that the crescent-shaped balloon 160 deploys the stent graft (100, 100′, 100″) which is initially in the substantially deflated position in the false lumen 26 (as shown in
In an embodiment as seen in
As seen in
As seen in
According to some embodiment, the stent graft (100,100′,100″) may have an integrated sealing ring (not seen) either on the top edge 114 or bottom edge 116 or both top and bottom edges 114,116 of the inner and outer grafts 112,118 to achieve better conformability and therefore sealing against the wall of the false lumen. The sealing ring may have a circular, annular or sinusoidal shape and comprise of an expansible material such as foam, hydrogels and so on, which allow for crimping of the stent graft (100,100′ 100″) in a catheter tube and expand after deployment.
An exemplary method of treating an aortic dissection will now be described with reference to
Firstly, an aortic dissection is located in the aorta 20 using any conventional techniques known in the art. Afterwards, a true lumen stent graft 170 is deployed in a true lumen 28 of an aortic dissection of the aorta 20. Afterwards, a stent graft (100, 100′, 100″) is introduced via re-entry point 12 in the false lumen 26 of an aortic dissection such that the stent graft (100, 100′, 100″) is deployed at or in the proximity of the re-entry point 12 in the false lumen 26. The geometry and the constructional features of the stent graft (100, 100′, 100″) blocks blood flow from flowing through the false lumen 26. Wherein the true lumen stent graft 170 is configured to allow blood flow from flowing through the true lumen 28.
The system and method for treatment of aortic dissection involving use of a stent graft (100, 100′, 100″) of the present invention including various components, parts thereof may be configured in many different shapes, sizes and using different kinds of materials, including but not limited to metals, plastics, ceramics, composites, polymers, rubber, silicone and one should not construed these aspects to be a limiting factor for the invention disclosed herein.
It should be understood that the various parts of the various embodiments of stent graft (100, 100′, 100″) of the present invention are similar and interchangeable. It is obvious to the one skilled in the art that the various parts of stent graft (100, 100′, 100″) of one embodiment of the present invention could be considered for other embodiments with little or no variation.
It should be understood according to the preceding description of the present invention that the same is susceptible to changes, modifications and adaptations, and that the said changes, modifications and adaptations fall within scope of the appended claims.
This patent application claims the benefit of priority of U.S. Provisional Patent Application No. 63/136,644, titled “NOVEL DEVICE FOR TREATMENT OF AORTIC DISSECTIONS”, filed on Jan. 13, 2021, which is hereby incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/AU2022/050012 | 1/13/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63136644 | Jan 2021 | US |